Aera Therapeutics is a new venture recently started with the aim to explore the unexplored areas of genetic medicines and biotechnology to its fullest.
|Company Name||CEO||Fund Raised||Invested By||No Of Investors|
|Aera Therapeutics||Akin Akinc||$193M||Lux Capital, ARCH Venture Partners and GV||3|
The company emerged with a mix of series A and B round funding from various investors for $193m. The three main investors for this funding round were Lux Capital, ARCH Venture Partners, and GV.
Also, read Sikoia Raises $6M in Seed Funding
The CEO, Akin Akinc started Aera Therapeutics with a vision to unlock the natural tendency of the human body to produce a human protein with the help of genetic medicines.